Market Share of Non-Hodgkin Lymphoma Therapeutics Industry
The non-Hodgkin lymphoma therapeutics market is highly competitive and consists of several major players. The factors owing to the competition include rising initiatives from the key market players for the launch of innovative therapies, partnerships for drug development, and rising advancements in cancer research, among others. Some of the companies operating in the market include AstraZeneca, Baxter International Inc., Bayer AG, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Eli Lilly and Co., F. Hoffmann La-Roche Ltd, and GlaxoSmithKline PLC.
Non-Hodgkin Lymphoma Therapeutics Market Leaders
AstraZeneca PLC
Bayer AG
F. Hoffmann La-Roche Ltd
Teva Pharmaceutical Industries Ltd
Seagen Inc
*Disclaimer: Major Players sorted in no particular order
